OBJECTIVE: To review clinical application and research progress of different types of intelligent responsive hydrogels in repairing articular cartilage injury. METHODS: The animal experiments and clinical studies of different types of intelligent responsive hydrogels for repairing articular cartilage injury were summarized by reviewing relevant literature at home and abroad. RESULTS: The intrinsic regenerative capacity of articular cartilage following injury is limited. Intelligent responsive hydrogels, including those that are temperature-sensitive, light-sensitive, enzyme-responsive, pH-sensitive, and other stimuli-responsive hydrogels, can undergo phase transitions in response to specific stimuli, thereby achieving optimal functionality. These hydrogels can fill the injured cartilage area, promote the proliferation and differentiation of chondrocytes, and expedite the repair of the damaged site. With advancements in cartilage tissue engineering materials research, intelligent responsive hydrogels offer a novel approach and promising potential for the treatment of cartilage injuries. CONCLUSION Intelligent responsive hydrogel is a kind of flexible, controllable, efficient, and stable polymer, which has similar structure and functional properties to articular cartilage, and has become one of the important biomaterials for cartilage repair. However, there is still a lack of unified treatment standards and simple and efficient preparation technology.
Hydrogels/therapeutic use* ; Cartilage, Articular/injuries* ; Tissue Engineering/methods* ; Humans ; Animals ; Chondrocytes/cytology* ; Biocompatible Materials/chemistry* ; Tissue Scaffolds/chemistry*

Objective:To mine the adverse event (AE) risk signals of semaglutide and liraglutide in weight management populations, and provide references for the safe use of these drugs in relevant patients.Methods:The reporting odds ratio (ROR) method, proportional reporting ratio (PRR) method, Bayesian confidence propagation neural network (BCPNN) method, and empirical Bayesian geometric mean (EBGM) method were used to mine the AE risk signals of semaglutide and liraglutide in weight management populations from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database from the 1st quarter of 2010 to the 4th quarter of 2023. Adverse events that met the criteria of all 4 mining methods were considered as risk signals. The adverse events were classified and statistically analyzed using the system organ class (SOC) and preferred term (PT) of the 26.1 version of the Medical Dictionary for Regulatory Activities 26.1 version, and the identified risk signals were analyzed. Results:During the set period, 2 292 AE reports for semaglutide for weight management (excluding diabetes) and 2 973 for liraglutide were retrieved. The semaglutide-related AE reports involved 83 PTs, among which 57 were already recorded in the instructions and 26 were not. Among the 26 PTs not recorded in the labels, the top 5 PTs in terms of AE report numbers were increased appetite, hunger, panic attack, binge eating, and feeling cold; the top 5 PTs in terms of ROR values were lack of satiety, hunger-induced ketoacidosis, myoglobinuria, binge eating, and bulimia. The liraglutide-related AE reports involved 74 PTs, among which 60 were already recorded in the instructions and 14 were not. Among the 14 PTs not recorded in the labels, the top 5 PTs in terms of AE report numbers were weight gain, increased appetite, binge eating, weight fluctuation, and pancreatic cyst; the top 5 PTs in terms of ROR values were lack of satiety, binge eating, hepatic adenoma, increased appetite, and pancreatic cyst. Three PTs of severe AEs that were not recorded in the labels for semaglutide were identified, namely, olfactory abnormality, ketoacidosis, and panic attack. One PT of severe AE that was not recorded in the labels for liraglutide was identified, namely, metastatic pancreatic cancer. Conclusion:The AE risk signals of semaglutide and liraglutide in weight management include AEs not recorded in the labels, and some are even serious AEs, which need to be identified and prevented in clinical practice.

Objective:To investigate the correlation among sex hormones, body mass index (BMI) , serum bone morphogenetic protein 15 (BMP-15) and bone metabolism parameters in adolescent patients with polycystic ovary syndrome (PCOS) .Methods:A total of 168 PCOS patients admitted from Aug. 2022 to Aug. 2023 were included in PCOS group, and 170 healthy adolescent women during the same period were included in the non-PCOS group. At the same time, the patients in PCOS group were divided into the obese group (n=81, BMI≥28 kg/m 2) and non-obese group (n=87, BMI < 25 kg/m 2) according to the BMI level. The levels of sex hormones, BMP-15 and bone metabolism indexes in all subjects were determined, and the correlation among sex hormones, BMI, BMP-15, bone metabolism indexes of PCOS patients was analyzed by Pearson correlation. Results:The levels of luteinizing hormone (LH) and testosterone (T) in PCOS group were higher ( t = 25.80, 27.99, P < 0.05) , and there was no statistically significant difference in follicle-stimulating hormone (FSH) levels between the two groups ( t = 1.73, P > 0.05) . The levels of LH and T in obese group were higher than those in the non-obese group ( t = 8.24, 23.90, P < 0.05) , and there was no statistically significant difference in FSH between the two groups ( t = 0.29, P > 0.05) . The BMP-15, osteocalcin and amino terminal propeptide (PINP) of type I collagen in PCOS group were lower than those in non-PCOS group ( t = 68.16, 65.89, 11.25, all P < 0.05) , and the cross-linked C-terminal peptide (CTX) of type I collagen was higher than those in non-PCOS group ( t = 13.01, P < 0.05) . BMP-15, osteocalcin and PINP in obese group were lower than those in non-obese group ( t = 14.74, 7.36, 7.90, all P < 0.05) , and CTX was higher ( t = 8.55, P < 0.05) . Pearson correlation analysis showed that LH was negatively correlated with BMP-15, osteocalcin and PINP in adolescent PCOS patients ( r= -0.42, -0.51, -0.42, P < 0.05) , and positively correlated with CTX ( r= 0.44, P < 0.05) . T was negatively correlated with BMP-15, osteocalcin and PINP ( r= -0.50, -0.49, -0.42, P < 0.05) , and positively correlated with CTX ( r= 0.48, P < 0.05) ; BMI was negatively correlated with BMP-15, osteocalcin and PINP ( r= -0.60, -0.66, -0.69, P < 0.05) , and positively correlated with CTX ( r= 0.70, P < 0.05) . Conclusions:In adolescent PCOS patients, LH, T and BMI is negatively correlated with BMP-15, osteocalcin and PINP, while positively correlated with CTX, indicating that PCOS and BMI can affect BMP-15 and bone metabolic markers, which has a certain correlation with ovarian function and abnormal bone metabolism.

Objective:To investigate the correlation among sex hormones, body mass index (BMI) , serum bone morphogenetic protein 15 (BMP-15) and bone metabolism parameters in adolescent patients with polycystic ovary syndrome (PCOS) .Methods:A total of 168 PCOS patients admitted from Aug. 2022 to Aug. 2023 were included in PCOS group, and 170 healthy adolescent women during the same period were included in the non-PCOS group. At the same time, the patients in PCOS group were divided into the obese group (n=81, BMI≥28 kg/m 2) and non-obese group (n=87, BMI < 25 kg/m 2) according to the BMI level. The levels of sex hormones, BMP-15 and bone metabolism indexes in all subjects were determined, and the correlation among sex hormones, BMI, BMP-15, bone metabolism indexes of PCOS patients was analyzed by Pearson correlation. Results:The levels of luteinizing hormone (LH) and testosterone (T) in PCOS group were higher ( t = 25.80, 27.99, P < 0.05) , and there was no statistically significant difference in follicle-stimulating hormone (FSH) levels between the two groups ( t = 1.73, P > 0.05) . The levels of LH and T in obese group were higher than those in the non-obese group ( t = 8.24, 23.90, P < 0.05) , and there was no statistically significant difference in FSH between the two groups ( t = 0.29, P > 0.05) . The BMP-15, osteocalcin and amino terminal propeptide (PINP) of type I collagen in PCOS group were lower than those in non-PCOS group ( t = 68.16, 65.89, 11.25, all P < 0.05) , and the cross-linked C-terminal peptide (CTX) of type I collagen was higher than those in non-PCOS group ( t = 13.01, P < 0.05) . BMP-15, osteocalcin and PINP in obese group were lower than those in non-obese group ( t = 14.74, 7.36, 7.90, all P < 0.05) , and CTX was higher ( t = 8.55, P < 0.05) . Pearson correlation analysis showed that LH was negatively correlated with BMP-15, osteocalcin and PINP in adolescent PCOS patients ( r= -0.42, -0.51, -0.42, P < 0.05) , and positively correlated with CTX ( r= 0.44, P < 0.05) . T was negatively correlated with BMP-15, osteocalcin and PINP ( r= -0.50, -0.49, -0.42, P < 0.05) , and positively correlated with CTX ( r= 0.48, P < 0.05) ; BMI was negatively correlated with BMP-15, osteocalcin and PINP ( r= -0.60, -0.66, -0.69, P < 0.05) , and positively correlated with CTX ( r= 0.70, P < 0.05) . Conclusions:In adolescent PCOS patients, LH, T and BMI is negatively correlated with BMP-15, osteocalcin and PINP, while positively correlated with CTX, indicating that PCOS and BMI can affect BMP-15 and bone metabolic markers, which has a certain correlation with ovarian function and abnormal bone metabolism.

Objective:To mine the adverse event (AE) risk signals of semaglutide and liraglutide in weight management populations, and provide references for the safe use of these drugs in relevant patients.Methods:The reporting odds ratio (ROR) method, proportional reporting ratio (PRR) method, Bayesian confidence propagation neural network (BCPNN) method, and empirical Bayesian geometric mean (EBGM) method were used to mine the AE risk signals of semaglutide and liraglutide in weight management populations from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database from the 1st quarter of 2010 to the 4th quarter of 2023. Adverse events that met the criteria of all 4 mining methods were considered as risk signals. The adverse events were classified and statistically analyzed using the system organ class (SOC) and preferred term (PT) of the 26.1 version of the Medical Dictionary for Regulatory Activities 26.1 version, and the identified risk signals were analyzed. Results:During the set period, 2 292 AE reports for semaglutide for weight management (excluding diabetes) and 2 973 for liraglutide were retrieved. The semaglutide-related AE reports involved 83 PTs, among which 57 were already recorded in the instructions and 26 were not. Among the 26 PTs not recorded in the labels, the top 5 PTs in terms of AE report numbers were increased appetite, hunger, panic attack, binge eating, and feeling cold; the top 5 PTs in terms of ROR values were lack of satiety, hunger-induced ketoacidosis, myoglobinuria, binge eating, and bulimia. The liraglutide-related AE reports involved 74 PTs, among which 60 were already recorded in the instructions and 14 were not. Among the 14 PTs not recorded in the labels, the top 5 PTs in terms of AE report numbers were weight gain, increased appetite, binge eating, weight fluctuation, and pancreatic cyst; the top 5 PTs in terms of ROR values were lack of satiety, binge eating, hepatic adenoma, increased appetite, and pancreatic cyst. Three PTs of severe AEs that were not recorded in the labels for semaglutide were identified, namely, olfactory abnormality, ketoacidosis, and panic attack. One PT of severe AE that was not recorded in the labels for liraglutide was identified, namely, metastatic pancreatic cancer. Conclusion:The AE risk signals of semaglutide and liraglutide in weight management include AEs not recorded in the labels, and some are even serious AEs, which need to be identified and prevented in clinical practice.

Objective To investigate the effect of the glutathione peroxidase 4(GPx4)on mouse so-matic cell reprogramming.Methods To compare the expressions of GPx4 in OG2 mouse embryonic fibroblast(OG2-MEF)cells(MEFs group)and mouse embryonic stem cells(mESC,mESCs group),the expression lev-el of intracellular GPx4 was determined by transcriptome sequencing technique and Western blot.To verify the effect of GPx4 on the efficiency of the somatic cells reprogramming,the complete open reading frame se-quence of GPx4 gene and its selenocysteine insertion sequence(SECIS)were connected to the retroviral vector pMXs for constructing the overexpressed plasmid pMXs-GPx4.Gpx4-targeting short hairpin RNA(shRNA)was synthesized and connected to pSUPER vector,GPx4 shRNA1 and GPx4 shRNA2 were constructed to knockdown GPx4 expression.The above plasmids were co-transfected with pMXs-Sox2,pMXs-Klf4 and pMXs-Oct4 into MEF cells for reprogramming induction to obtain the pMXs no-load control group(pMXs NC),pMXs GPx4 group,pSUPER no-load control group(pSUPER NC),GPx4 shRNA1 group and GPx4 shRNA2 group.The expressions of GPx4 gene and multifunctional marker genes Rex1,Sox2,Dappa3,Sall4,Oct4 and Nanog were detected by real-time fluorescence quantitative PCR.The induced pluripotent stem cells(iPSC)were detected by immunofluorescence staining;the number of iPSC clones generation was detected by alkaline phosphatase staining of pluripotent stem cells;the GPx4 protein expression was detected by Western blot.Results The mRNA and protein expression of GPx4 in the mESCs group was higher than that in the MEFs group;compared with the pMXs NC group,the expression level of GPx4 mRNA in the pMXs GPx4 group was significantly increased;compared with the pSUPER NC group,the GPx4 mRNA and protein levels in the GPx4 shRNA1 group and GPx4 shRNA2 group were decreased(P＜0.05);the iPSC clone number in the pMXs GPx4 group was higher than that in the pMXs NC group,but the difference was not statistically significant(P＞0.05).The number of iPSC clones in the GPx4 shRNA1 group and GPx4 shRNA2 group was significantly lower than that in the pSUPER NC group,and the difference was statistically significant(P＜0.05).After completing the reprogramming,compared with the original MEF cells,the expression levels of various pluripotent marker genes Rex1,Sox2,Dappa3,Sall4,Oct4 and Nanog in the generated iPSC of each group were increased.Conclusion GPx4 knockdown could inhibit the efficiency of somatic cell reprogram-ming,its generated induced pluripotent stem cells have the normal pluripotent gene expression ability.

Objective:To systematically evaluate and integrate the exercise experience of elderly people in pension institutions.Methods:Qualitative studies on exercise experience of the elderly in pension institutions were searched through PubMed, Cochrane Library, EMbase, Web of Science, VIP, Wanfang, China National Knowledge Infrastructure and China Biology Medicine disc. The retrieval period was from the establishment of the databases to March 8, 2022. The quality evaluation criteria of qualitative research of Joanna Briggs Institute (JBI) evidence-based health care center in Australia was used to evaluate the quality of the included studies, and the results were synthesized by integrating method.Results:A total of 14 studies were included, 58 research results were extracted, 3 integrated results (hindering factors, sports experience and promoting factors of exercise for the elderly in pension institutions) were summarized and 8 new categories were formed.Conclusions:Medical staff need to fully understand the exercise experience of the elderly in pension institutions and analyze their attitude, views and needs for exercise, so as to formulate effective exercise intervention strategies.

Objective:To explore the diagnostic value of chromosome karyotype analysis, chromosomal microarray analysis (CMA) and whole exome sequencing (WES) in microcephaly.Methods:A total of 9 cases of microcephaly fetuses diagnosed by prenatal ultrasound or children with microcephaly diagnosed after birth were selected from the Sixth Affiliated Hospital of Guangzhou Medical University from January 2014 to August 2022.Karyotype analysis and/or CMA were used to detect. The cases with negative karyotype analysis and CMA results were further sequenced by trio-based WES (Trio-WES). Then the coding genes contained in the pathogenic copy number variation (CNV) fragments were analyzed by gene ontology (GO) enrichment. The genes related to the development of the central nervous system contained in the pathogenic CNV and the pathogenic genes found by Trio-WES were combined for gene interaction network analysis.Results:In this study, 9 cases of microcephaly were recruited, with the time of diagnosis ranged from 23 weeks of gestation to 7 years after birth, and the head circumference of fetus or children ranged from 18.3 to 42.5 cm (-7SD to -2SD). Karyotype analysis was detected in all 9 cases and no abnormality result was found. Eight cases were detected by CMA, and one abnormal was found. Five cases were detected by Trio-WES, and two cases were detected with likely pathogenic genes. The GO enrichment analysis of the coding gene in the 4p16.3 microdeletion (pathogenic CNV) region showed that: in biological process, it was mainly concentrated in phototransduction, visible light; in terms of molecular function, it was mainly concentrated in fibroblast growth factor binding; in terms of cell components, it was mainly concentrated in rough endoplasmic reticulum. Gene interaction network analysis suggested that CDC42 gene could interact with CTBP1, HTT and ASPM gene.Conclusions:CMA could be used as a first-line detection technique for microcephaly. When the results of chromosome karyotype analysis and/or CMA are negative, Trio-WES could improve the detection rate of pathogenicity of microcephaly.

Objective To quantify operation characteristics of the ankle rotating-traction-poking manipulation (RTPM) for treating acute lateral ankle sprain by using motion capture technology, so as to provide objective references for standardized operation of RTPM and its education inheritance. Methods A professional physiotherapist performed the RTPM on 60 volunteers with acute lateral ankle sprain. Motion capture system was used to acquire effective kinematic data during the RTPM, so as to make analysis and summarize rules. Results The average time of ankle rotating for six circles was 11.36 s and the average time of ankle traction and poking was 3.42 s. The average displacement of ankle traction was 36.94 mm and the average displacement of ankle poking was 22.44 mm. The average angle of ankle traction was 23.27°, and the average angle of ankle poking was 22.76°. During the RTPM for treating acute lateral ankle sprain, the average linear velocity of ankle rotating was 58.28 mm/s, and the average linear velocity of ankle traction and poking was 23.81 mm/s. The linear acceleration of ankle rotating was 0.43 mm/s2, and the linear acceleration of ankle traction and poking was 0.54 mm/s2. Conclusions The RTPM can be applied in clinical practice. During the RTMP, the principle of gentleness, rhythmicity and continuity should be followed. Under the premise of following physiological characteristics of ankle joint, treatment of the sprained ankle should be carried out with slow and uniform speed continuously.

Objective:To explore the effect and difference of percutaneous coronary intervention (PCI) and medical therapy on quality of life and cognitive function in patients with coronary heart disease (CHD),and to investigate the relationship between quality of life and cognitive function.Methods:A total of 320 patients with CHD,who underwent coronary angiography and PCI (PCI group,n=160),or underwent coronary angiography and medical therapy (drug therapy group,n=160),were selected.The quality of life was assessed by using the Health Survey Form SF-36 (SF-36) and the Seattle Angina Questionnaire (SAQ),and the cognitive function was assessed by using the Mini-Mental State Examination (MMSE).General data of patients were collected on the day of coronary angiography.Telephone follow-up was conducted in 1 month after treatment,and the outpatient review was carried out in 3 and 6 months after treatment.Results:A total of 309 valid questionnaires were collected.The scores of quality of life in the PCI group and the drug therapy group after treatment were both increased compared with those before treatment (both P＜0.05).The SF-36 scores of four dimensions (role physical,bodily pain,vitality and mental health) in the PCI group were all significantly greater than those in the drug therapy group (all P＜0.05).The SAQscores of two dimensions (angina stability and angina frequency) were both higher in the PCI group than those in the drug therapy group in 6 months of post-operation (all P＜0.05).There was no significant difference in cognitive function before and after the treatment in the 2 groups (P＞0.05).There was no significant difference in cognitive function between the PCI group and the drug therapy group (P＞0.05).In the PCI group,physical function,role physical,bodily pain,and role emotional were positively correlated with cognitive function (r=0.207,0.182,0.184,0.176 respectively,all P＜0.05).In the drug therapy group,there was no correlation between quality of life and cognitive function.Conclusion:The quality of life for the patients is improved in the PCI group and the drug therapy group,but the improvement degree in the PCI group is more obvious.Both PCI and drug therapy do not result in the decrease of cognitive function,and there is no difference between the 2 groups.There is positive correlation between quality of life and cognitive function in the PCI group,there is no correlation between quality of life and cognitive function in the drug therapy group.